Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr-cas9
7
×
boston blog main
boston top stories
gene editing
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
national
boulder/denver blog main
boulder/denver top stories
cancer
crispr
crispr therapeutics
detroit blog main
detroit top stories
editas medicine
fda
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
cancer immunotherapy
clinical trials
deals
dna
eidos therapeutics
eli lilly
What
crispr
cas
editing
gene
medicine
roundup
bio
cancer
cells
days
editas
genetic
new
potential
researchers
scientists
today
university
address
ahead
alliance
ambien
american
annual
approach
asco
attendees
attention
beam
big
biotech
body
bosley's
bosley’s
bridge
bristol
bucks
buy
california
calls
Language
unset
Current search:
crispr-cas9
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@digitaltrends.com
4 years ago
CRISPR-Cas9 gene editing could one day ‘turn off’ HIV virus in the body
@engadget.com
4 years ago
Gene editing tool could treat many diseases created by mutations
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M